Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Alkermes Introduces Alixorexton for the Treatment of Narcolepsy Type 1
Alkermes has introduced alixorexton for the treatment of narcolepsy type 1 (NT1), a chronic neurological disorder characterised by excessive daytime sleepiness and disrupted regulation of wakefulness.
Plixorafenib - A Novel Therapy Introduced for the Treatment of High-Grade Glioma
FORE Biotherapeutics has introduced plixorafenib for the treatment of adult patients with BRAF V600E-mutated high-grade glioma (HGG), an aggressive form of brain cancer associated with poor outcomes and limited treatment options.
Sanofi Introduces Breakthrough Venglustat Therapy for Treating Type 3 Gaucher Disease
Sanofi has introduced venglustat for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare inherited lysosomal storage disorder.
Novo Nordisk Introduced First and Only Awiqli® for Type 2 Diabetes
Novo Nordisk has introduced Awiqli® (insulin icodec-abae), the first and only once-weekly basal insulin for adults with type 2 diabetes.
Relay Therapeutics Receives Breakthrough Therapy Designation for Zovegalisib for the Treatment of Advanced Breast Cancer
Relay Therapeutics has introduced zovegalisib for the treatment of patients with PIK3CA-mutant, hormone receptor-positive, HER2-negative advanced breast cancer, a common subtype of breast cancer characterised by mutations that promote tumour growth and progression.
Johnson & Johnson Receives Breakthrough Therapy Designation for RYBREVANT FASPRO™ for the Treatment of Advanced Head and Neck Cancer
Johnson & Johnson has introduced RYBREVANT FASPRO™ for the treatment of patients with advanced head and neck squamous cell carcinoma (HNSCC).
Neurogene Introduces Breakthrough NGN-401 Gene Therapy for the Treatment of Rett Syndrome
Neurogene has introduced NGN-401 for the treatment of patients with Rett syndrome, a rare neurological disorder characterised by severe developmental and functional impairments.
Encoded Therapeutics has Introduced ETX101 for the Treatment of Patients with Dravet Syndrome
Encoded Therapeutics has introduced ETX101 for the treatment of SCN1A+ Dravet syndrome, a rare and severe genetic neurological disorder that begins in early childhood.
Sanofi Introduces Breakthrough Rilzabrutinib for the Treatment of Warm Autoimmune Haemolytic Anaemia
Sanofi has introduced rilzabrutinib for the treatment of patients with warm autoimmune haemolytic anaemia (wAIHA), a rare autoimmune disorder characterised by the destruction of red blood cells.
Novartis Introduces Breakthrough Ianalumab for the Treatment of Sjögren’s Disease
Novartis has introduced ianalumab for the treatment of patients with Sjögren’s disease, a chronic autoimmune condition that affects the body’s moisture-producing glands and can involve multiple organs.
